NTRK inhibitors (Blueprint Medicines)

N/A

Report date: 2025/06/11 10:30:20
NME

Base Information

Drug NameNTRK inhibitors (Blueprint Medicines)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTropomyosin-related kinase inhibitorsAnticancer protein kinase inhibitors
TargetsTropomyosin-related kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlueprint Medicines Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlueprint Medicines Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A